Related Experiment Video
Updated: Mar 7, 2026
Author Spotlight: Understanding the Propagation of Closed Circular Extrachromosomal rDNA Containing Element (CERE) in Naegleria gruberi
Published on: June 21, 2024
Targeting Brain-Eating Amoebae Infections
Naveed Ahmed Khan1, Timothy Yu Yee Ong1, Ruqaiyyah Siddiqui1
1Department of Biological Sciences, Faculty of Science and Technology, Sunway University , Selangor, 47500, Malaysia.
Abstract:
Brain infections due to Acanthamoeba spp., Balamuthia mandrillaris, and Naegleria fowleri often lead to death. Despite differences in the preferential sites of infection in the brain, the mode of delivery of drugs is often intravenous. Here, we discuss targeted therapeutic approach to affect parasite viability without affecting the host cells, with an eye to improve formulation of drugs and/or administration of drugs against brain-eating amoebae.
Insights
Fatal brain infections from Acanthamoeba, Balamuthia, and Naegleria fowleri necessitate improved drug delivery. This study explores targeted therapies to enhance drug formulation and administration against these brain-eating amoebae.
Area of Science:
- Neuroparasitology
- Pharmacology
- Drug Delivery Systems
Background:
- Brain infections caused by Acanthamoeba spp., Balamuthia mandrillaris, and Naegleria fowleri are frequently fatal.
- Current treatments often rely on intravenous drug administration, despite varying infection sites within the brain.
Purpose of the Study:
- To discuss a targeted therapeutic strategy for brain-eating amoebae.
- To improve drug formulation and administration for enhanced efficacy.
- To develop treatments that selectively target amoebic parasites without harming host cells.
Main Methods:
- Review and discussion of existing literature on amoebic brain infections.
- Exploration of targeted drug delivery mechanisms.
- Analysis of potential improvements in drug formulation.
Main Results:
- Identification of challenges in treating amoebic brain infections.
- Conceptualization of targeted approaches to enhance drug viability.
- Focus on non-host-cell-affecting therapeutic strategies.
Conclusions:
- Targeted therapeutic approaches are crucial for improving outcomes in brain-eating amoeba infections.
- Optimizing drug formulation and administration can increase treatment effectiveness.
- Developing selective therapies is key to reducing host toxicity.
